[1] 姜燕飞, 戴智勇, 李勇. 早产儿母乳喂养对其生理、营养和 临床表现的影响[J]. 中国生育健康杂志, 2015, 26(4): 379-382.
[2] Carling S, Demment MM, Kjolhede CL, et al. Breastfeeding duration and weight gain trajectory in infancy[J]. Pediatrics, 2015, 135(1): 111-119.
[3] Yamakawa M, Yorifuji T, Inoue S, et al. Breastfeeding and obesity among schoolchildren: a nationwide longitudinal survey in Japan[J]. JAMA Pediatr, 2013, 167(10): 919-925.
[4] Bergström A, Skov TH, Bahl MI, et al. Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants[J]. Appl Environ Microbiol, 2014, 80(9): 2889-2900.
[5] Underwood MA, Gaerlan S, De Leoz ML, et al. Human milk oligosaccharides in premature infants: absorption, excretion, and influence on the intestinal microbiota[J]. Pediatr Res, 2015, 78(6): 670-677.
[6] Zhou J, Shukla VV, John D, et al. Human milk feeding as a protective factor for retinopathy of prematurity: a metaanalysis[ J]. Pediatrics, 2015, 136(6): e1576-e1586.
[7] Josephson CD, Caliendo AM, Easley KA, et al. Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study[J]. JAMA Pediatr, 2014, 168(11): 1054-1062.
[8] 汪德海, 高楠, 于磊. 献血人群人巨细胞病毒检验筛查策略 的建立[J]. 北京医学, 2015, 37(8): 801-803.
[9] Álvarez Domínguez E, Figueras Aloy J, Botet Mussons F, et al. Screening for cytomegalovirus infection in very low birth weight infants[J]. An Pediatr (Barc), 2013, 79(1): 3-9.
[10] 裴蕴锋. 小儿巨细胞病毒感染状况分析[J]. 检验医学与临床 杂志, 2013, 10(8): 980-981.
[11] 北京地区母婴巨细胞病毒感染调查协作组. 北京地区母婴巨 细胞病毒感染状况调查[J]. 中华围产医学杂志, 2012, 15(8): 459-461.
[12] 润袁敏, 管建, 徐春芬. 武汉地区儿童感染巨细胞病毒状况[J]. 广东医学杂志, 2013, 34(18): 2849-2851.
[13] Kurath S, Halwachs-Baumann G, Müller W, et al. Transmission of cytomegalovirus via breast milk to the prematurely born infant: a systematic review[J]. Clin Microbiol Infect, 2010, 16(8): 1172-1178.
[14] Arellano-Galindo J, Villanueva-García D, Cruz-Ramirez JL, et al. Detection and gB genotyping of CMV in Mexican preterm infants in the context of maternal seropositivity[J]. J Infect Dev Ctries, 2014, 8(6): 758-767.
[15] Ehlinger EP, Webster EM, Kang HH, et al. Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants[J]. J Infect Dis, 2011, 204(11): 1672-1682.
[16] Gunkel J, Wolfs TF, de Vries LS, et al. Predictors of severity for postnatal cytomegalovirus infection in preterm infants and implications for treatment[J]. Expert Rev Anti Infect Ther, 2014, 12(11): 1345-1355.
[17] Kurath S, Halwachs-Baumann G, Müller W, et al. Transmission of cytomegalovirus via breast milk to the prematurely born infant: a systematic review[J]. Clin Microbiol Infect, 2010, 16(8): 1172-1178.
[18] Alarcón Allen A, Baquero-Artigao F; Grupo de estudio de la infección por citomegalovirus de la Sociedad Española de Infectología Pediátrica. Review and guidelines on the prevention, diagnosis and treatment of post-natal cytomegalovirus infection[J]. An Pediatr (Barc), 2011, 74(1): 52.e1-52.e13.
[19] Nijman J, de Vries LS, Koopman-Esseboom C, et al. Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings[J]. Arch Dis Child Fetal Neonatal Ed, 2012, 97(4): 259-263.
[20] Mehler K, Oberthuer A, Lang-Roth R, et al. High rate of symptomatic cytomegalovirus infection in extremely low gestational age preterm infants of 22-24 weeks' gestation after transmission via breast milk[J]. Neonatology, 2014, 105(1): 27-32.
[21] Tengsupakul S, Birge ND, Bendel CM, et al. Asymptomatic DNAemia heralds CMV-associated NEC: case report, review, and rationale for preemption[J]. Pediatrics, 2013, 132(5): e1428-e1434.
[22] Takahashi R, Tagawa M, Sanjo M, et al. Severe postnatal cytomegalovirus infection in a very premature infant[J]. Neonatology, 2007, 92(4): 236-239.
[23] Neuberger P, Hamprecht K, Vochem M, et al. Case-control study of symptoms and neonatal outcome of human milk-transmitted cytomegalovirus infection in premature infants[J]. J Pediatr, 2006, 148(3): 326-331.
[24] Kimberlin DW, Jester PM, Sánchez PJ, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease[J]. N Engl J Med, 2015, 372(10): 933-943.
[25] Jim WT, Chiu NC, Ho CS, et al. Outcome of preterm infants with postnatal cytomegalovirus infection via breast milk: a twoyear prospective follow-up study[J]. Medicine (Baltimore), 2015, 94(43): e1835.
[26] Goelz R, Meisner C, Bevot A, et al. Long-term cognitive and neurological outcome of preterm infants with postnatally acquired CMV infection through breast milk[J]. Arch Dis Child Fetal Neonatal Ed, 2013, 98(5): 430-433.
[27] Yoo HS, Sung SI, Jung YJ, et al. Prevention of cytomegalovirus transmission via breast milk in extremely low birth weight infants[J]. Yonsei Med J, 2015, 56(4): 998-1006.
[28] Lanzieri TM, Dollard SC, Josephson CD, et al. Breast milkacquired cytomegalovirus infection and disease in VLBW and premature infants[J]. Pediatrics, 2013, 131(6): 1937-1945.
[29] Chiavarini M, Bragetti P, Sensini A. Breastfeeding and transmission of cytomegalovirus to preterm infants. Case report and kinetic of CMV-DNA in breast milk[J]. Ital J Pediatr, 2011, 37: 6.
[30] Hayashi S, Kimura H, Oshiro M, et al. Transmission of cytomegalovirus via breast milk in extremely premature infants[J]. J Perinatol, 2011, 31(6): 440-445.
[31] Omarsdottir S, Casper C, Navér L, et al. Cytomegalovirus infection and neonatal outcome in extremely preterm infants after freezing of maternal milk[J]. Pediatr Infect Dis J, 2015, 34(5): 482-489.
[32] Gomes FP, Shaw PN, Whitfield K, et al. Effect of pasteurisation on the concentrations of vitamin D compounds in donor breastmilk[J]. Int J Food Sci Nutr, 2016, 67(1): 16-19.
[33] 李淑娟, 曹云. 早产儿经母乳获得性巨细胞病毒感染的研究 进展[J]. 中华围产医学杂志, 2014, 17(11): 773-777.
[34] Meier PP, Engstrom JL, Patel AL, et al. Improving the use of human milk during and after the NICU stay[J]. Clin Perinatol, 2010, 73(1): 217-245.
[35] Dempsey AF, Pangborn HM, Prosser LA. Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus[J]. Vaccine, 2012, 30(27): 4060-4066.
[36] Nigro G, Capretti I, Manganello AM, et al. Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight[J]. J Matern Fetal Neonatal Med, 2015, 28(2): 168-171.
[37] Revello MG, Lazzarotto T, Guerra B, et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus[J]. N Engl J Med, 2014, 370(14): 1316-1326.